Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aytu Biopharma, Inc (AYTU) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aytu Biopharma, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1385818.
Total stock buying since 2016: $7,408,795.
Total stock sales since 2016: $18,342,392.
Total stock option exercises since 2016: $10,466,933.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 98,332 | $144,498 | 0 | $0 | 314 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 209 | $0 |
| 2023 | 26,000 | $48,510 | 0 | $0 | 1,874 | $0 |
| 2022 | 212,371 | $49,558 | 0 | $0 | 0 | $0 |
| 2020 | 1,333,334 | $4,000,002 | 27,228,499 | $18,339,682 | 20,229,161 | $9,795,372 |
| 2019 | 133,788 | $82,769 | 0 | $0 | 0 | $0 |
| 2018 | 518,810 | $233,464 | 3,330 | $2,710 | 0 | $0 |
| 2017 | 0 | $0 | 0 | $0 | 895,416 | $671,561 |
| 2016 | 5,741,023 | $2,849,994 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 83,332 | $124,998 | 0 | $0 | 0 | $0 |
| 2025-03 | 0 | $0 | 0 | $0 | 209 | $0 |
| 2025-02 | 15,000 | $19,500 | 0 | $0 | 105 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 209 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 209 | $0 |
| 2023-09 | 0 | $0 | 0 | $0 | 624 | $0 |
| 2023-06 | 26,000 | $48,510 | 0 | $0 | 208 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 833 | $0 |
| 2022-12 | 212,371 | $49,558 | 0 | $0 | 0 | $0 |
| 2020-12 | 1,333,334 | $4,000,002 | 0 | $0 | 0 | $0 |
| 2020-04 | 0 | $0 | 5,201,698 | $4,793,200 | 5,000,000 | $3,125,000 |
| 2020-03 | 0 | $0 | 22,026,801 | $13,546,482 | 15,229,161 | $6,670,372 |
| 2019-12 | 133,788 | $82,769 | 0 | $0 | 0 | $0 |
| 2018-12 | 0 | $0 | 3,330 | $2,710 | 0 | $0 |
| 2018-03 | 518,810 | $233,464 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 895,416 | $671,561 |
| 2016-11 | 433,331 | $649,996 | 0 | $0 | 0 | $0 |
| 2016-05 | 5,000,000 | $2,000,000 | 0 | $0 | 0 | $0 |
| 2016-01 | 307,692 | $199,998 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-09 | Disbrow Jarrett (Chief Business Officer) | Buy | 16,666 | 1.50 | 24,999 |
| 2025-06-09 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 66,666 | 1.50 | 99,999 |
| 2025-03-31 | Pyszczymuka Greg (Chief Commercial Officer) | Option Ex | 209 | .00 | 0 |
| 2025-02-28 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 15,000 | 1.30 | 19,500 |
| 2025-02-05 | Selhorn Ryan J (Chief Financial Officer) | Option Ex | 105 | .00 | 0 |
| 2024-09-30 | Pyszczymuka Greg (Chief Commercial Officer) | Option Ex | 209 | .00 | 0 |
| 2023-12-31 | Pyszczymuka Greg (Chief Commercial Officer) | Option Ex | 209 | .00 | 0 |
| 2023-09-30 | Pyszczymuka Greg (Chief Commercial Officer) | Option Ex | 416 | .00 | 0 |
| 2023-06-30 | Pyszczymuka Greg (Chief Commerical Officer) | Option Ex | 208 | .00 | 0 |
| 2023-06-16 | Pyszczymuka Greg (Chief Commerical Officer) | Buy | 12,000 | 1.87 | 22,428 |
| 2023-06-14 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 14,000 | 1.86 | 26,082 |
| 2023-04-25 | Pyszczymuka Greg (Chief Commerical Officer) | Option Ex | 833 | .00 | 0 |
| 2022-12-19 | Pyszczymuka Greg (Chief Commercial Officer) | Buy | 100,000 | .24 | 24,500 |
| 2022-12-19 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 112,371 | .22 | 25,058 |
| 2020-12-11 | Boyd Steven | Buy | 1,333,334 | 3.00 | 4,000,002 |
| 2020-04-27 | Boyd Steven | Sale | 5,108,921 | .91 | 4,649,118 |
| 2020-04-27 | Boyd Steven | Option Ex | 5,000,000 | .62 | 3,125,000 |
| 2020-04-15 | Cerecor Inc. (10% Owner) | Sale | 92,777 | 1.55 | 144,082 |
| 2020-03-10 | Boyd Steven | Sale | 22,026,801 | .61 | 13,546,482 |
| 2020-03-10 | Boyd Steven | Option Ex | 15,229,161 | .44 | 6,670,372 |
| 2019-12-20 | Boyd Steven | Buy | 26,000 | .44 | 11,440 |
| 2019-12-19 | Boyd Steven | Buy | 52,788 | .42 | 22,434 |
| 2019-12-19 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 55,000 | .89 | 48,895 |
| 2018-12-21 | Green David A (Chief Financial Officer) | Sale | 3,330 | .81 | 2,710 |
| 2018-03-06 | Disbrow Jarrett (Chief Operating Officer) | Buy | 226,105 | .45 | 101,747 |
| 2018-03-06 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 226,105 | .45 | 101,747 |
| 2018-03-06 | Green David A (Chief Financial Officer) | Buy | 66,600 | .45 | 29,970 |
| 2017-02-27 | Cantrell Gary (Director) | Option Ex | 37,083 | .75 | 27,812 |
| 2017-02-27 | Disbrow Jarrett (Chief Operating Officer) | Option Ex | 187,500 | .75 | 140,625 |
| 2017-02-27 | Dockery Carl (Director) | Option Ex | 416,667 | .75 | 312,500 |
| 2017-02-27 | Disbrow Joshua R. (Chief Executive Officer) | Option Ex | 187,500 | .75 | 140,625 |
| 2017-02-27 | Gould Gregory A (Chief Financial Officer) | Option Ex | 66,666 | .75 | 49,999 |
| 2016-11-02 | Cantrell Gary (Director) | Buy | 33,333 | 1.50 | 49,999 |
| 2016-11-02 | Disbrow Jarrett (Chief Operating Officer) | Buy | 166,666 | 1.50 | 249,999 |
| 2016-11-02 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 166,666 | 1.50 | 249,999 |
| 2016-11-02 | Gould Gregory A (Chief Financial Officer) | Buy | 66,666 | 1.50 | 99,999 |
| 2016-05-06 | Dockery Carl (Director) | Buy | 5,000,000 | .40 | 2,000,000 |
| 2016-01-20 | Disbrow Jarrett (Chief Operating Officer) | Buy | 153,846 | .65 | 99,999 |
| 2016-01-20 | Disbrow Joshua R. (Chief Executive Officer) | Buy | 153,846 | .65 | 99,999 |
Insider trading activities including stock purchases, stock sales, and option exercises of AYTU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aytu Biopharma, Inc (symbol AYTU, CIK number 1385818) see the Securities and Exchange Commission (SEC) website.